Quarterly report pursuant to Section 13 or 15(d)

Note 7 - STOCKHOLDERS' DEFICIT (Details)

v3.19.1
Note 7 - STOCKHOLDERS' DEFICIT (Details) - USD ($)
3 Months Ended 12 Months Ended
Jan. 25, 2019
Jan. 14, 2019
Aug. 28, 2018
Aug. 08, 2018
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Sep. 19, 2018
Sep. 18, 2018
Note 7 - STOCKHOLDERS' DEFICIT (Details) [Line Items]                  
Preferred Stock, Shares Authorized         10,000,000   10,000,000 10,000,000  
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)         $ 0.001   $ 0.001    
Preferred Stock, Shares Issued         0   0    
Common Stock, Shares Authorized         200,000,000   200,000,000 200,000,000 50,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)         $ 0.001   $ 0.001    
Common Stock, Voting Rights         The holders of common stock are entitled to one vote for each share of common stock held at the time of vote.        
Common Stock, Shares, Outstanding         19,218,958   19,205,624    
Consulting Agreement, Quaterly Shares (in Dollars)     $ 5,000 $ 5,000          
Consulting Agreement, Quaterly Shares, Maximum Shares     6,667 6,667          
Stock Issued During Period, Shares, Issued for Services     6,667 6,667          
Shares Issued, Price Per Share (in Dollars per share)     $ 0.04 $ 0.04          
Stock Issued During Period, Value, Issued for Services (in Dollars)     $ 280 $ 280 $ 561        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 800,000           1,800,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.75 $ 0.75     $ 0.75        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights 200,000 vest on the one year anniversary of the date of grant and the remaining 600,000 shares vest ratably on a quarterly basis over the following two years vest over a 24-month period as follows: 25% (or 200,000 and 50,000, respectively) shall vest six months after the grant date with the remaining options will vest on a monthly basis at a rate of 1/24th per month. The options will expire on January 14, 2029              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share) $ 13,714 $ 17,111              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 10 years 10 years              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   77.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   2.71%              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00% 0.00%              
Share Price (in Dollars per share) $ 0.042 $ 0.042              
Share-based Payment Arrangement, Noncash Expense (in Dollars)         $ 4,334 $ 0      
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award Under certain circumstances, the Company would be obligated to grant options to purchase an additional 200,000 shares at substantially similar terms.                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 77.00%                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 2.76%                
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount (in Dollars)         26,491        
Board of Directors Chairman [Member]                  
Note 7 - STOCKHOLDERS' DEFICIT (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   800,000              
President [Member]                  
Note 7 - STOCKHOLDERS' DEFICIT (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   200,000              
Options Granted January 14, 2019 [Member]                  
Note 7 - STOCKHOLDERS' DEFICIT (Details) [Line Items]                  
Share-based Payment Arrangement, Noncash Expense (in Dollars)         3,114        
Options Granted January 25, 2019 [Member]                  
Note 7 - STOCKHOLDERS' DEFICIT (Details) [Line Items]                  
Share-based Payment Arrangement, Noncash Expense (in Dollars)         $ 1,220